Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

13,122 total articles

McGrath RentCorp Director Joseph Hanna Offloads $904,817 in Stock

McGrath RentCorp Director Joseph Hanna Offloads $904,817 in Stock

McGrath RentCorp (NASDAQ:MGRC) director Joseph F. Hanna executed a significant sale of common stock on July 1, 2026, disposing of 7,500 shares for a total value of $904,817. The transactions occurred at weighted average prices between $119.208 and $121.2318 per share. Following the sale, Hanna retains direct ownership of 151,549 shares. The sale co…

Block Director Sells Shares Under Pre-Existing Trading Plan

Block Director Sells Shares Under Pre-Existing Trading Plan

Block, Inc. director Anthony Mathew Eisen executed a series of stock sales totaling $3,805,020 between June 30 and July 2, 2026. The transactions, conducted under a Rule 10b5-1 trading plan established in March 2026, involved the liquidation of 48,000 Class A shares at prices ranging from $76.40 to $80.00. Following these dispositions, Eisen retain…

Cerus CEO William Greenman Executes Pre-Arranged Stock Sale

Cerus CEO William Greenman Executes Pre-Arranged Stock Sale

Cerus Corporation (NASDAQ: CERS) President and CEO William Greenman completed a series of stock transactions on June 30, 2026, resulting in the sale of common stock valued at approximately $299,937. The transactions were executed under a Rule 10b5-1 plan to satisfy statutory tax withholding and brokerage fees associated with the vesting of restrict…

Nektar Therapeutics R&D Chief Sells $397,670 of Common Stock

Nektar Therapeutics R&D Chief Sells $397,670 of Common Stock

Jonathan Zalevsky, Chief R&D Officer at Nektar Therapeutics (NASDAQ:NKTR), executed a sale of 5,681 shares of common stock on June 30, 2026, totaling $397,670. The transaction, conducted at $70.00 per share, was carried out under a pre-established Rule 10b5-1 trading plan adopted in March 2026. Following the sale, Zalevsky retains direct ownership …